Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor

Ping WengFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information

Shu YangFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information

Shujuan XuFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information

Shuxia ZhangFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information

Yong WuFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information

Yuanzhong ChenFujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date